Dose escalation in lung cancer: have we gone full circle?

Lancet Oncol. 2015 Feb;16(2):125-7. doi: 10.1016/S1470-2045(15)70001-X. Epub 2015 Jan 16.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adenocarcinoma / therapy*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Large Cell / therapy*
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Carcinoma, Squamous Cell / therapy*
  • Chemoradiotherapy*
  • Female
  • Humans
  • Lung Neoplasms / therapy*
  • Male